Long-Term Risk of Stroke and Poststroke Outcomes in Patients with Heart Failure: Two Nationwide Studies

References

• GBD. 2016 stroke collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–458.30871944
   PubMed Web of Science ®Google Scholar
• Boehme AK, Esenwa C, Elkind MSV. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472–495. doi:10.1161/CIRCRESAHA.116.30839828154098
   PubMed Web of Science ®Google Scholar
• GBD. 2017 disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1789–1858.30496104
   PubMed Web of Science ®Google Scholar
• Cook C, Cole G, Asaria P, et al. The annual global economic burden of heart failure. Int J Cardiol. 2014;171(3):368–376. doi:10.1016/j.ijcard.2013.12.02824398230
   PubMed Web of Science ®Google Scholar
• Kim W, Kim EJ. Heart failure as a risk factor for stroke. J Stroke. 2018;20(1):33–45. doi:10.5853/jos.2017.0281029402070
   PubMed Web of Science ®Google Scholar
• Dries DL, Rosenberg YD, Waclawiw MA, et al. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials. J Am Coll Cardiol. 1997;29(5):1074–1080. doi:10.1016/S0735-1097(97)00019-39120162
   PubMed Web of Science ®Google Scholar
• Witt BJ, Brown RD Jr, Jacobsen SJ, et al. Ischemic stroke after heart failure: a community-based study. Am Heart J. 2006;152(1):102–109. doi:10.1016/j.ahj.2005.10.01816824838
   PubMed Web of Science ®Google Scholar
• Hays AG, Sacco RL, Rundek T, et al. Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. Stroke. 2006;37(7):1715–1719. doi:10.1161/01.STR.0000227121.34717.4016741172
   PubMed Web of Science ®Google Scholar
• Freudenberger RS, Hellkamp AS, Halperin JL, et al. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2007;115(20):2637–2641. doi:10.1161/CIRCULATIONAHA.106.66139717485579
   PubMed Web of Science ®Google Scholar
• Pullicino PM, McClure LA, Wadley VG, et al. Blood pressure and stroke in heart failure in the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study. Stroke. 2009;40(12):3706–3710. doi:10.1161/STROKEAHA.109.56167019834015
   PubMed Web of Science ®Google Scholar
• Alberts VP, Bos MJ, Koudstaal P, et al. Heart failure and the risk of stroke: the Rotterdam Study. Eur J Epidemiol. 2010;25(11):807–812. doi:10.1007/s10654-010-9520-y21061046
   PubMed Web of Science ®Google Scholar
• Lip GYH, Rasmussen LH, Skjøth F, et al. Stroke and mortality in patients with incident heart failure: the Diet, Cancer and Health (DCH) cohort study. BMJ Open. 2012;2(4):e000975. doi:10.1136/bmjopen-2012-000975
   PubMed Web of Science ®Google Scholar
• Abdul-Rahim AH, Perez AC, Fulton RL, et al. Risk of stroke in chronic heart failure patients without atrial fibrillation: analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell’Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials. Circulation. 2015;131(17):1486–1494.25810334
   PubMed Web of Science ®Google Scholar
• Adelborg K, Szépligeti S, Sundbøll J, et al. Risk of stroke in patients with heart failure: a population-based 30-year cohort study. Stroke. 2017;48(5):1161–1168. doi:10.1161/STROKEAHA.116.01602228377383
   PubMed Web of Science ®Google Scholar
• Kang S-H, Kim J, Park JJ, et al. Risk of stroke in congestive heart failure with and without atrial fibrillation. Int J Cardiol. 2017;248:182–187. doi:10.1016/j.ijcard.2017.07.05628826798
   PubMed Web of Science ®Google Scholar
• Mogensen UM, Jhund PS, Abraham WT, et al. Type of atrial fibrillation and outcomes in patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(20):2490–2500. doi:10.1016/j.jacc.2017.09.02729145948
   PubMed Web of Science ®Google Scholar
• Abdul-Rahim AH, Perez AC, MacIsaac RL, et al. Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-preserved and I-preserve trials. Eur Heart J. 2017;38(10):742–750.28426886
   PubMed Web of Science ®Google Scholar
• Liao -C-C, Chou Y-C, Yeh C-C, et al. Stroke risk and outcomes in patients with traumatic brain injury: 2 nationwide studies. Mayo Clin Proc. 2014;89(2):163–172. doi:10.1016/j.mayocp.2013.09.01924485130
   PubMed Web of Science ®Google Scholar
• Liao CC, Chang PY, Yeh CC, et al. Outcomes after surgery in patients with previous stroke. Br J Surg. 2014;101(12):1616–1622. doi:10.1002/bjs.963925224956
   PubMed Web of Science ®Google Scholar
• Crespo-Leiro MG, Metra M, Lund LH, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2018;20(11):1505–1535.29806100
   PubMed Web of Science ®Google Scholar
• Amarenco P, Labreuche J. Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol. 2009;8(5):453–463. doi:10.1016/S1474-4422(09)70058-419375663
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang M, Torres G, et al. Metformin suppresses diabetes-accelerated atherosclerosis via the inhibition of Drp1-mediated mitochondrial fission. Diabetes. 2017;66(1):193–205. doi:10.2337/db16-091527737949
   PubMed Web of Science ®Google Scholar
• Goldberg RB, Aroda VR, Bluemke DA, et al. Effect of long-term metformin and lifestyle in the diabetes prevention program and its outcome study on coronary artery calcium. Circulation. 2017;136(1):52–64. doi:10.1161/CIRCULATIONAHA.116.02548328476766
   PubMed Web of Science ®Google Scholar
• Di Tullio MR, Qian M, Thompson JLP, et al. Left ventricular ejection fraction and risk of stroke and cardiac events in heart failure: data from the warfarin versus aspirin in reduced ejection fraction trial. Stroke. 2016;47(8):2031–2037. doi:10.1161/STROKEAHA.116.01367927354224
   PubMed Web of Science ®Google Scholar
• Shantsila E, Lip GYH. Thrombotic complications in heart failure: an underappreciated challenge. Circulation. 2014;130(5):387–389. doi:10.1161/CIRCULATIONAHA.114.01135324970781
   PubMed Web of Science ®Google Scholar
• Verbrugge FH, Tang WH, Mullens W. Renin-angiotensin-aldosterone system activation during decongestion in acute heart failure: friend or foe? JACC Heart Fail. 2015;3(2):108–111. doi:10.1016/j.jchf.2014.10.00525543974
   PubMed Web of Science ®Google Scholar
• Havakuk O, King KS, Grazette L, et al. Heart failure-induced brain injury. J Am Coll Cardiol. 2017;69(12):1609–1616. doi:10.1016/j.jacc.2017.01.02228335844
   PubMed Web of Science ®Google Scholar
• Vemmos K, Ntaios G, Savvari P, et al. Stroke aetiology and predictors of outcome in patients with heart failure and acute stroke: a 10-year follow-up study. Eur J Heart Fail. 2012;14(2):211–218.22200911
   PubMed Web of Science ®Google Scholar
• Melkonian M, Jarzebowski W, Pautas E, et al. Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis. J Thromb Haemost. 2017;15(7):1500–1510. doi:10.1111/jth.1369728393461
   PubMed Web of Science ®Google Scholar
• Barasa A, Schaufelberger M, Lappas G, et al. Heart failure in young adults: 20-year trends in hospitalization, aetiology, and case fatality in Sweden. Eur Heart J. 2014;35(1):25–32. doi:10.1093/eurheartj/eht27823900697
   PubMed Web of Science ®Google Scholar
• Wong CM, Hawkins NM, Jhund PS, et al. Clinical characteristics and outcomes of young and very young adults with heart failure: the CHARM programme (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity). J Am Coll Cardiol. 2013;62(20):1845–1854. doi:10.1016/j.jacc.2013.05.07223850914
   PubMed Web of Science ®Google Scholar
• Beggs SAS, Rørth R, Gardner RS, et al. Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis. Heart. 2019;105(17):1325–1334. doi:10.1136/heartjnl-2018-31438130962190
   PubMed Web of Science ®Google Scholar
• Shpak M, Ramakrishnan A, Nadasdy Z, et al. Higher incidence of ischemic stroke in patients taking novel oral anticoagulants. Stroke. 2018;49(12):2851–2856. doi:10.1161/STROKEAHA.118.02263630571404
   PubMed Web of Science ®Google Scholar
• Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003;34(1):122–126. doi:10.1161/01.STR.0000047852.05842.3C12511762
   PubMed Web of Science ®Google Scholar
• Divani AA, Vazquez G, Asadollahi M, et al. Nationwide frequency and association of heart failure on stroke outcomes in the United States. J Card Fail. 2009;15(1):11–16. doi:10.1016/j.cardfail.2008.09.00119181288
   PubMed Web of Science ®Google Scholar
• Shi K, Wood K, Shi FD, et al. Stroke-induced immunosuppression and poststroke infection. Stroke Vasc Neurol. 2018;3(1):34–41.29600006
   PubMedGoogle Scholar
• Giede-Jeppe A, Bobinger T, Gerner ST, et al. Lymphocytopenia is an independent predictor of unfavorable functional outcome in spontaneous intracerebral hemorrhage. Stroke. 2016;47(5):1239–1246. doi:10.1161/STROKEAHA.116.01300327073240
   PubMed Web of Science ®Google Scholar
• Feldman AM, Combes A, Wagner D, et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol. 2000;35(3):537–544. doi:10.1016/S0735-1097(99)00600-210716453
   PubMed Web of Science ®Google Scholar
• Kalogeropoulos A, Georgiopoulou V, Psaty BM, et al. Inflammatory markers and incident heart failure risk in older adults: the health ABC (health, aging, and body composition) study. J Am Coll Cardiol. 2010;55(19):2129–2137. doi:10.1016/j.jacc.2009.12.04520447537
   PubMed Web of Science ®Google Scholar
• Nagarajan V, Hernandez AV, Cauthen CA, et al. Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure. Am Heart J. 2017;183:35–39. doi:10.1016/j.ahj.2016.09.00827979039
   PubMed Web of Science ®Google Scholar
• Mehra MR, Vaduganathan M, Fu M, et al. A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial. Eur Heart J. 2019;40(44):3593–3602. doi:10.1093/eurheartj/ehz42731461239
   PubMed Web of Science ®Google Scholar
• Badve MS, Zhou Z, Anderson CS, et al. Effectiveness and safety of antibiotics for preventing pneumonia and improving outcome after acute stroke: systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2018;27(11):3137–3147. doi:10.1016/j.jstrokecerebrovasdis.2018.07.00130093207
   PubMed Web of Science ®Google Scholar
• Kalra L, Irshad S, Hodsoll J, et al. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet. 2015;386(10006):1835–1844. doi:10.1016/S0140-6736(15)00126-926343840
   PubMed Web of Science ®Google Scholar
• Shinohara Y, Origasa H. Post-stroke pneumonia prevention by angiotensin-converting enzyme inhibitors: results of a meta-analysis of five studies in Asians. Adv Ther. 2012;29(10):900–912. doi:10.1007/s12325-012-0049-122983755
   PubMed Web of Science ®Google Scholar
• Bath PM, Lee HS, Everton LF. Swallowing therapy for dysphagia in acute and subacute stroke. Cochrane Database Syst Rev. 2018;10(10):CD000323.30376602
   PubMed Web of Science ®Google Scholar